SS
AQST icon

Steve Schonfeld’s Aquestive Therapeutics AQST Stock Holding History

Steve Schonfeld’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.3K Sell
12,081
-39,736
-77% -$167K ﹤0.01% 2380
2026
Q1 		$215K Buy
51,817
+33,013
+176% +$134K ﹤0.01% 1708
2025
Q4 		$121K Sell
18,804
-10,139
-35% -$63.2K ﹤0.01% 1791
2025
Q3 		$162K Buy
+28,943
New +$125K ﹤0.01% 1977
2024
Q2 		– Sell
-62,747
Closed -$267K – 2131
2024
Q1 		$267K Buy
+62,747
New +$209K ﹤0.01% 1696
2023
Q3 		– Sell
-16,900
Closed -$27.9K – 1757
2023
Q2 		$27.9K Buy
+16,900
New +$30.6K ﹤0.01% 1867
2023
Q1 		– Sell
-506,600
Closed -$457K – 2080
2022
Q4 		$457K Buy
506,600
+99,900
+25% +$93.8K ﹤0.01% 1577
2022
Q3 		$475K Buy
406,700
+325,600
+401% +$368K ﹤0.01% 1790
2022
Q2 		$52K Sell
81,100
-18,900
-19% -$25.1K ﹤0.01% 2216
2022
Q1 		$261K Sell
100,000
-5,700
-5% -$16.6K ﹤0.01% 1770
2021
Q4 		$411K Buy
+105,700
New +$530K ﹤0.01% 1365
2018
Q4 		– Sell
-11,192
Closed -$196K – 1048
2018
Q3 		$196K Buy
+11,192
New +$184K 0.01% 761

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Steve Schonfeld's AQST Position: Q2 2026 in Review

Steve Schonfeld reduced its Aquestive Therapeutics (AQST) stake by 77% in Q2 2026, selling an estimated $167K and leaving 12,081 shares worth $50.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

Steve Schonfeld first reported a position in AQST in Q3 2018 and has held it in 12 quarters since. The position peaked at $475K in Q3 2022. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Steve Schonfeld held 12,081 shares of Aquestive Therapeutics worth $50.3K as of Q2 2026.
  • Steve Schonfeld sold 39,736 Aquestive Therapeutics shares in Q2 2026, an estimated $167K.
  • Aquestive Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2380 holding.
  • Steve Schonfeld first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 12 quarters since.
  • Steve Schonfeld's Aquestive Therapeutics position peaked at $475K in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.